TRUST CO OF VERMONT - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 63 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,770
-19.7%
1,0000.0%0.00%0.0%
Q2 2023$9,680
-11.7%
1,0000.0%0.00%0.0%
Q1 2023$10,960
+153.7%
1,0000.0%0.00%
Q4 2022$4,320
-46.0%
1,0000.0%0.00%
-100.0%
Q3 2022$8,000
-20.0%
1,0000.0%0.00%0.0%
Q2 2022$10,000
-56.5%
1,0000.0%0.00%0.0%
Q4 2021$23,000
+76.9%
1,0000.0%0.00%0.0%
Q2 2021$13,0000.0%1,0000.0%0.00%0.0%
Q1 2021$13,000
-7.1%
1,0000.0%0.00%0.0%
Q4 2020$14,000
-6.7%
1,0000.0%0.00%0.0%
Q3 2020$15,000
-6.2%
1,0000.0%0.00%
-50.0%
Q2 2020$16,000
+6.7%
1,0000.0%0.00%
+100.0%
Q1 2020$15,000
-25.0%
1,0000.0%0.00%
-50.0%
Q4 2019$20,000
+300.0%
1,0000.0%0.00%
Q3 2019$5,000
-28.6%
1,0000.0%0.00%
-100.0%
Q2 2019$7,0000.0%1,0000.0%0.00%0.0%
Q1 2019$7,0000.0%1,0000.0%0.00%0.0%
Q4 2018$7,0000.0%1,0000.0%0.00%0.0%
Q3 2018$7,000
+16.7%
1,0000.0%0.00%0.0%
Q2 2018$6,000
+20.0%
1,0000.0%0.00%
Q1 2018$5,0000.0%1,0000.0%0.00%
Q4 2017$5,000
-16.7%
1,0000.0%0.00%
-100.0%
Q3 2017$6,0001,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders